Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 221

1.

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L; DAPT Study Investigators.

J Am Coll Cardiol. 2017 Oct 31;70(18):2213-2223. doi: 10.1016/j.jacc.2017.09.011.

PMID:
29073947
2.

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.

Giustino G, Mehran R, Dangas GD, Kirtane AJ, Redfors B, Généreux P, Brener SJ, Prats J, Pocock SJ, Deliargyris EN, Stone GW.

J Am Coll Cardiol. 2017 Oct 10;70(15):1846-1857. doi: 10.1016/j.jacc.2017.08.018.

PMID:
28982497
3.

Percutaneous Coronary Intervention of Saphenous Vein Graft.

Redfors B, Généreux P, Witzenbichler B, McAndrew T, Diamond J, Huang X, Maehara A, Weisz G, Mehran R, Kirtane AJ, Stone GW.

Circ Cardiovasc Interv. 2017 May;10(5). pii: e004953. doi: 10.1161/CIRCINTERVENTIONS.117.004953.

4.

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.

Lindholm D, Hagström E, James SK, Becker RC, Cannon CP, Himmelmann A, Katus HA, Maurer G, López-Sendón JL, Steg PG, Storey RF, Siegbahn A, Wallentin L.

J Am Heart Assoc. 2017 Apr 14;6(4). pii: e005580. doi: 10.1161/JAHA.117.005580.

5.

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.

Alfredsson J, Neely B, Neely ML, Bhatt DL, Goodman SG, Tricoci P, Mahaffey KW, Cornel JH, White HD, Fox KA, Prabhakaran D, Winters KJ, Armstrong PW, Ohman EM, Roe MT; TRILOGY ACS Investigators.

Heart. 2017 Aug;103(15):1168-1176. doi: 10.1136/heartjnl-2016-310090. Epub 2017 Apr 5.

PMID:
28381584
6.

Validation of Bleeding Classifications in Coronary Artery Bypass Grafting.

Brascia D, Reichart D, Onorati F, Perrotti A, Ruggieri VG, Bounader K, Verhoye JP, Santarpino G, Fischlein T, Maselli D, Dominici C, Mariscalco G, Gherli R, Rubino AS, De Feo M, Bancone C, Gatti G, Santini F, Dalén M, Saccocci M, Faggian G, Tauriainen T, Kinnunen EM, Nicolini F, Gherli T, Rosato S, Biancari F.

Am J Cardiol. 2017 Mar 1;119(5):727-733. doi: 10.1016/j.amjcard.2016.11.027. Epub 2016 Dec 3.

PMID:
28024656
7.

Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

Cornel JH, Ohman EM, Neely B, Jakubowski JA, Bhatt DL, White HD, Ardissino D, Fox KA, Prabhakaran D, Armstrong PW, Erlinge D, Tantry US, Gurbel PA, Roe MT.

J Am Heart Assoc. 2016 Nov 4;5(11). pii: e003977.

8.

"Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.

Larmore C, Effron MB, Molife C, DeKoven M, Zhu Y, Lu J, Karkare S, Lieu HD, Lee WC, Vetrovec GW.

Catheter Cardiovasc Interv. 2016 Oct;88(4):535-544. doi: 10.1002/ccd.26279. Epub 2015 Nov 18.

9.

Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment.

Tomšič A, Schotborgh MA, Manshanden JS, Li WW, de Mol BA.

Eur J Cardiothorac Surg. 2016 Nov;50(5):849-856. Epub 2016 May 12.

PMID:
27174551
10.

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.

Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P.

J Am Coll Cardiol. 2016 May 10;67(18):2135-2144. doi: 10.1016/j.jacc.2016.02.056.

11.

Continued vorapaxar versus withdrawed clopidogrel both on top of low dose aspirin in patients undergoing heart surgery: A call for randomized trial.

Serebruany VL, Kim MH, Golukhova E, Pya Y, Bekbossynova M, Cattaneo M, Marciniak TA.

Int J Cardiol. 2016 Jul 15;215:273-6. doi: 10.1016/j.ijcard.2016.04.124. Epub 2016 Apr 17.

PMID:
27128545
12.

Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow.

Bedeir K, Bliden K, Tantry U, Gurbel PA, Mahla E.

Can J Cardiol. 2016 Jun;32(6):724-5. doi: 10.1016/j.cjca.2016.01.038. Epub 2016 Feb 8.

PMID:
27094125
13.

Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.

Nagashima Z, Tsukahara K, Uchida K, Hibi K, Karube N, Ebina T, Imoto K, Kimura K, Umemura S.

J Cardiol. 2017 Jan;69(1):156-161. doi: 10.1016/j.jjcc.2016.02.013. Epub 2016 Mar 15.

14.

The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgery.

Leunissen TC, Janssen PW, Ten Berg JM, Moll FL, Korporaal SJ, de Borst GJ, Pasterkamp G, Urbanus RT.

Vascul Pharmacol. 2016 Feb;77:19-27. doi: 10.1016/j.vph.2015.12.002. Epub 2015 Dec 24. Review.

PMID:
26724555
15.

[Impact of preoperative dual antiplatelet therapy on perioperative bleeding in patients undergoing off-pump coronary artery bypass grafting].

Zhang J, Huang F, Yang J, Wu Q, Liu Y, Zhou Y, Zou Y, Zhu E.

Zhonghua Yi Xue Za Zhi. 2015 Jun 23;95(24):1934-7. Chinese.

PMID:
26710697
16.

Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.

O'Connor SA, Amour J, Mercadier A, Martin R, Kerneis M, Abtan J, Brugier D, Silvain J, Barthélémy O, Leprince P, Montalescot G, Collet JP; ACTION Study Group.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002786. doi: 10.1161/CIRCINTERVENTIONS.115.002786.

17.

Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery.

Kuliczkowski W, Sliwka J, Kaczmarski J, Zysko D, Zembala M, Steter D, Zembala M, Fortmann S, Serebruany V.

Clin Cardiol. 2015 Nov;38(11):679-83. doi: 10.1002/clc.22472. Epub 2015 Oct 8.

18.

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.

Hagström E, James SK, Bertilsson M, Becker RC, Himmelmann A, Husted S, Katus HA, Steg PG, Storey RF, Siegbahn A, Wallentin L; PLATO Investigators.

Eur Heart J. 2016 Apr 21;37(16):1325-33. doi: 10.1093/eurheartj/ehv491. Epub 2015 Sep 28.

PMID:
26417057
19.

Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.

Hansson EC, Jidéus L, Åberg B, Bjursten H, Dreifaldt M, Holmgren A, Ivert T, Nozohoor S, Barbu M, Svedjeholm R, Jeppsson A.

Eur Heart J. 2016 Jan 7;37(2):189-97. doi: 10.1093/eurheartj/ehv381. Epub 2015 Sep 1.

20.

Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.

Takiuchi H, Tanemoto K.

Gen Thorac Cardiovasc Surg. 2015 Nov;63(11):601-6. doi: 10.1007/s11748-015-0583-2. Epub 2015 Aug 23. Erratum in: Gen Thorac Cardiovasc Surg. 2015 Nov;63(11):607.

PMID:
26298730

Supplemental Content

Loading ...
Support Center